Therefore, the identification of genes and mechanisms behind newly found genetic associations, such as for p16INK4a, will provide new insights and therapeutic possibilities for targeting atherosclerosis and type 2 diabetes. The gene discussed is CDKN2A; the disease is atherosclerosis.